Actinium Pharmaceuticals
ATNM
#9708
Rank
S$48.75 M
Marketcap
$1.56
Share price
-4.88%
Change (1 day)
-82.54%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -S$59.6 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are S$0.08 Million. In 2023 the company made an earning of -S$69.36 Million a decrease over its 2022 earnings that were of -S$45.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$59.6 Million-14.09%
2023 -S$69.36 Million52.24%
2022 -S$45.56 Million36.61%
2021 -S$33.35 Million11.48%
2020 -S$29.92 Million1.46%
2019 -S$29.49 Million-7.37%
2018 -S$31.84 Million-11.46%
2017 -S$35.96 Million10.67%
2016 -S$32.49 Million15.7%
2015 -S$28.08 Million-14.86%
2014 -S$32.98 Million129.19%
2013 -S$14.39 Million-8.55%
2012 -S$15.74 Million
2010 S$0.01 M-152.15%
2009 -S$0.03 Million-39.8%
2008 -S$0.04 Million120.29%
2007 -S$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$49.69 Million-17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.52 B-970.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$91.31 Million 52.03%๐Ÿ‡บ๐Ÿ‡ธ USA